Toggle Main Menu Toggle Search

Open Access padlockePrints

In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.

Lookup NU author(s): Dr Katherine Sturgess, Dr Rachel Dickinson, Professor Andrew GenneryORCiD, Professor Andrew Cant, Professor Graham Jackson, Professor Sophie HambletonORCiD, Professor Mary Slatter, Dr Venetia BigleyORCiD, Professor Matthew CollinORCiD



This is the authors' accepted manuscript of an article that has been published in its final definitive form by American Society of Hematology, 2018.

For re-use rights please refer to the publisher's terms and conditions.


Key points • Fludarabine-based reduced intensity transplantation with T depletion is safe and effective • Severe infection or respiratory compromise are indications for transplantation, even in the absence of myeloid neoplasia

Publication metadata

Author(s): Tholouli E, Sturgess K, Dickinson RE, Gennery A, Cant AJ, Jackson G, Lordan J, Hambleton S, Slatter MA, Bigley V, Collin M

Publication type: Article

Publication status: Published

Journal: Blood

Year: 2018

Volume: 131

Issue: 12

Pages: 1383-1387

Online publication date: 02/01/2018

Acceptance date: 18/12/2017

Date deposited: 26/01/2018

ISSN (print): 0006-4971

ISSN (electronic): 1528-0020

Publisher: American Society of Hematology


DOI: 10.1182/blood-2017-10-811489

PubMed id: 29295841


Altmetrics provided by Altmetric